ENTRY       D01021                      Drug
NAME        Naphazoline nitrate (JP18);
            Privine (TN)
FORMULA     C14H14N2. HNO3
EXACT_MASS  273.1113
MOL_WEIGHT  273.2872
CLASS       Cardiovascular agent
             DG01456  Adrenergic receptor agonist
              DG01450  alpha-Adrenergic receptor agonist
               DG01448  alpha1-Adrenergic receptor agonist
REMARK      Therapeutic category: 1316 1324
            ATC code: R01AA08 R01AB02 S01GA01
            Chemical structure group: DG01032
            Product (DG01032): D01021<JP>
EFFICACY    Vasoconstrictor, alpha1-Adrenergic receptor agonist
COMMENT     Imidazoline derivative
TARGET      ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]
  PATHWAY   hsa04080(146+147+148)  Neuroactive ligand-receptor interaction
            hsa04270(146+147+148)  Vascular smooth muscle contraction
INTERACTION  
STR_MAP     map07114  Naphthalene family
            map07215  alpha-Adrenergic receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R01 NASAL PREPARATIONS
               R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
                R01AA Sympathomimetics, plain
                 R01AA08 Naphazoline
                  D01021  Naphazoline nitrate (JP18) &lt;JP&gt;
                R01AB Sympathomimetics, combinations excl. corticosteroids
                 R01AB02 Naphazoline
                  D01021  Naphazoline nitrate (JP18) &lt;JP&gt;
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01G DECONGESTANTS AND ANTIALLERGICS
                S01GA Sympathomimetics used as decongestants
                 S01GA01 Naphazoline
                  D01021  Naphazoline nitrate (JP18) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1316  Ophthalmic local vasoconstrictors
                 D01021  Naphazoline nitrate (JP18)
               132  Otic and nasal agents
                1324  Otolaryngologic vasoconstrictors
                 D01021  Naphazoline nitrate (JP18)
            Risk category of Japanese OTC drugs [BR:br08312]
             Second-class OTC drugs
              Inorganic and organic chemicals
               Naphazoline
                D01021  Naphazoline nitrate (JP18)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01456  Adrenergic receptor agonist
               DG01450  alpha-Adrenergic receptor agonist
                DG01448  alpha1-Adrenergic receptor agonist
                 DG01032  Naphazoline
                  D01021  Naphazoline nitrate
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRA1
                 D01021  Naphazoline nitrate (JP18) &lt;JP&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D01021  Naphazoline nitrate
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01456  Adrenergic receptor agonist
               DG01450  alpha-Adrenergic receptor agonist
                DG01448  alpha1-Adrenergic receptor agonist
                 DG01032  Naphazoline
DBLINKS     CAS: 5144-52-5
            PubChem: 7848084
            ChEBI: 7471
            LigandBox: D01021
            NIKKAJI: J300.553D
ATOM        20
            1   N2b N    36.3244  -19.0105 #+
            2   O3a O    36.3186  -17.6140
            3   O3a O    37.5567  -19.7146 #-
            4   O1b O    35.1065  -19.7205
            5   C8y C    28.2800  -18.6900
            6   C8y C    29.4700  -17.9900
            7   C8y C    28.2800  -20.0900
            8   C8x C    27.0900  -17.9900
            9   C1b C    29.4700  -16.5900
            10  C8x C    30.8000  -18.6900
            11  C8x C    29.4700  -20.7900
            12  C8x C    27.0900  -20.7900
            13  C8x C    25.8300  -18.6900
            14  C2y C    30.7300  -15.8900
            15  C8x C    30.8000  -20.0900
            16  C8x C    25.8300  -20.0900
            17  N1x N    32.0600  -16.3800
            18  N2x N    30.7300  -14.5600
            19  C1x C    32.9000  -15.1900
            20  C1x C    32.0600  -14.0700
BOND        21
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     5   6 1
            5     5   7 2
            6     5   8 1
            7     6   9 1
            8     6  10 2
            9     7  11 1
            10    7  12 1
            11    8  13 2
            12    9  14 1
            13   10  15 1
            14   12  16 2
            15   14  17 1
            16   14  18 2
            17   17  19 1
            18   18  20 1
            19   11  15 2
            20   13  16 1
            21   19  20 1
///
